InterbrandHealth is pleased to announce an expanding commitment to its healthcare mission and vision with the elevation of John Breen to Executive Director, Brand Intelligence & Experience. John will continue to be based in New York and report to InterbrandHealth CEO Jane Parker.
This broadened role will allow John, formerly Executive Director of Analytics, to address complex client needs in the rapidly changing healthcare ecosystem. John will combine InterbrandHealth’s strategic thinking with analytical insights to increase customer engagement and create stronger connections through brand experience.
“John has been a dedicated member of InterbrandHealth for many years, providing key insights for our clients through in-depth research and smart thinking. As health and healthcare become more consumer-centric, understanding the impact of the brand experience on one’s bottom line- and how to measure it- will be crucial to future success,” Jane commented.
In his new role John will continue to oversee the InterbrandHealth analytics team, advising clients on how to maximize the impact of their brand investments.
Since joining InterbrandHealth in July 1999, John has worked extensively with global healthcare clients to explore, assess, and value their brands. He has worked with a wide rage of clients within the healthcare industry, including biopharmaceutical (Pfizer, GSK, Eli Lilly, Roche, Genentech, Novartis and Alexion) medical device and diagnostics companies (Medtronic, DePuy Synthes, Quest Diagnostics), health systems (The Children’s Hospital of Philadelphia, Trinity Health, HCA, Seattle Cancer Care Alliance) and payers (United Healthcare).
John holds a BS in Communications from Cornell University and an MBA from New York University’s Stern School of Business.